|Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe|
Providing the latest business, scientific, and regulatory news for the pharmaceutical and biotech industries.
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
Industry Briefs: August 27, 2012
Bend Research has opened a new cGMP spray-drying facility for high-potency drugs in Bend, Oregon. Read More
Bristol-Myers Squibb (BMS) has discontinued the development of BMS-986094, an investigational nucleotide polymerase inhibitor for treating hepatitis C. Read More
Claris Lifesciences has announced that it has ended its supply agreement with Pfizer. Read More
FDA has approved Gilead’s Stribild, a once-daily, single tablet regimen for treating HIV. Read More
Sanofi’s subsidiary Genzyme has received a Refuse to File letter from FDA for its biologics license application for Lemtrada (alemtuzumab), a monoclonal antibody to treat relapsing multiple sclerosis. The agency requested that the company modify the presentation of the data sets to enable the agency to better navigate the application. Read More
Synergy Pharmaceuticals has acquired FV-100, an orally available nucleoside analogue for treating shingles, from BMS. Read More
West Pharmaceutical India Packaging, an indirect subsidiary of West Pharmaceutical Services, has begun construction of its new compression molding facility in Sri City, India. The plant will become part of West’s global supply chain for its pharmaceutical packaging operations. Read More
The Wistar Institute of Philadelphia has signed a three-year collaborative agreement with DavosPharma to develop novel therapeutics. Read More
WuXi PharmaTech has agreed with TaiMed Biologics to manufacture Ibalizumab (TMB-355) in support of Phase II and III clinical trials. Read More
DPT Laboratories has named Gene Ciolfi vice-president and general manager of the company’s Center Excellence for Sterile and Specialty Products. Read More
Hovione has appointed Conrad Winters as the company’s drug product development director. Read More
Roche has appointed Daniel O’Day as the head of Roche Pharma, effective Sept. 1, 2012. Roland Diggelmann will assume the position head of Roche diagnostics. Read More